Genelux (GNLX) Current Leases (2022 - 2026)

Genelux's (GNLX) quarterly Current Leases came in at $316000.0 in Q1 2026, down 26.0% quarter-over-quarter from $427000.0 in Q4 2025.

Genelux (GNLX) Current Leases (2022 - 2026) Analysis & Trends

Genelux's Current Leases history runs 5 years deep, the most recent figure standing at $316000.0 for Q1 2026.

  • On a quarterly basis, Current Leases changed N/A year-over-year to $316000.0 in Q1 2026; TTM through Mar 2026 was $316000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $427000.0, up 29.79% from the prior year.
  • Current Leases declined to $316000.0 in Q1 2026 per GNLX's latest filing, from $427000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $653000.0 in Q4 2023 and bottomed at $266000.0 in Q4 2022.
  • The 5-year median for Current Leases is $415000.0 (2024), against an average of $432363.6.
  • Across the five-year window, Current Leases soared 145.49% in 2023 and sank 49.62% in 2024, its largest moves.
  • Year by year, Current Leases stood at $266000.0 in 2022, then soared by 145.49% to $653000.0 in 2023, then sank by 49.62% to $329000.0 in 2024, then grew by 29.79% to $427000.0 in 2025, then retreated by 26.0% to $316000.0 in 2026.
  • Per Business Quant, the three latest GNLX Current Leases figures stand at $316000.0 (Q1 2026), $427000.0 (Q4 2025), and $354000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 531,233.95
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 20.58 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 720.00 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 11.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 16.61 Mn
10 Genelux 129.36 Mn 129.36 Mn - 316,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 316,000.00
Dec 31, 2025 427,000.00
Sep 30, 2025 354,000.00
Jun 30, 2025 345,000.00
Dec 31, 2024 329,000.00
Sep 30, 2024 415,000.00
Jun 30, 2024 500,000.00
Mar 31, 2024 584,000.00
Dec 31, 2023 653,000.00
Sep 30, 2023 567,000.00
Dec 31, 2022 266,000.00